Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor Boger RH; Ron ESAltern Med Rev 2005[Mar]; 10 (1): 14-23There is abundant evidence that the endothelium plays a crucial role in the maintenance of vascular tone and structure. One of the major endothelium-derived vasoactive mediators is nitric oxide (NO), an endogenous messenger molecule formed in healthy vascular endothelium from the amino acid precursor L-arginine. Endothelial dysfunction is caused by various cardiovascular risk factors, metabolic diseases, and systemic or local inflammation. One mechanism that explains the occurrence of endothelial dysfunction is the presence of elevated blood levels of asymmetric dimethylarginine (ADMA)--an L-arginine analogue that inhibits NO formation and thereby can impair vascular function. Supplementation with L-arginine has been shown to restore vascular function and to improve the clinical symptoms of various diseases associated with vascular dysfunction.|Arginine/*analogs & derivatives/metabolism/*therapeutic use[MESH]|Arteriosclerosis/blood[MESH]|Cardiovascular Diseases/drug therapy/*etiology/metabolism[MESH]|Endothelium, Vascular/*metabolism/physiology[MESH]|Humans[MESH]|Nitric Oxide Synthase Type III[MESH]|Nitric Oxide Synthase/metabolism[MESH]|Nitric Oxide/*metabolism[MESH] |